首页> 外文期刊>American Journal of Transplantation >Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression
【24h】

Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression

机译:缬更昔洛韦和断奶的免疫抑制治疗肝移植后多中心Castleman病。

获取原文
获取原文并翻译 | 示例
           

摘要

Multicentric Castleman disease is a lymphoproliferative disorder which when seen in the setting of HIV/AIDS is often associated with human herpes virus 8 (HHV-8) infection. We describe the case of a HIV-negative man who developed HHV-8-associated multicentric Castleman disease 11 years after liver transplantation. The patient presented with fevers and weight loss. Physical examination revealed enlarged cervical, axillary and inguinal lymph nodes. Widespread lymphadenopathy was confirmed on computed tomography (CT) scanning. Histology of an enlarged lymph node showed a polymorphous infiltrate with mature plasma cells, plasmacytoid lymphocytes and occasional blasts within the cortex and paracortex. The diagnosis of Castleman disease was confirmed by the finding of numerous HHV-8-immunopositive cells around the regressed lymph node follicles and the detection of HHV-8 on plasma PCR. Although the conventional treatment for this condition has been combination chemotherapy, in the post-transplant context it was decided to treat the patient with valganciclovir and cessation of immunosuppression. His symptoms resolved rapidly and repeat plasma PCR done 3 months after starting treatment was negative for HHV-8. A follow-up CT scan showed a dramatic reduction in the size and amount of lymphadenopathy. After 15 months of treatment, he remains well with no evidence of graft dysfunction or rejection.
机译:多中心Castleman病是一种淋巴增生性疾病,在HIV / AIDS的环境中观察到,通常与人类疱疹病毒8(HHV-8)感染有关。我们描述了一个在肝移植后11年发展为HHV-8相关性多中心Castleman病的HIV阴性男子的案例。该患者出现发烧和体重减轻。体格检查发现宫颈,腋窝和腹股沟淋巴结肿大。在计算机断层扫描(CT)扫描中证实了广泛的淋巴结肿大。淋巴结肿大的组织学表现为多态性浸润,成熟皮浆细胞,浆细胞样淋巴细胞以及皮层和副皮层内偶尔出现胚泡。通过在退化的淋巴结滤泡周围发现大量HHV-8免疫阳性细胞,并通过血浆PCR检测HHV-8,证实了Castleman病的诊断。尽管针对这种疾病的常规治疗方法是联合化疗,但在移植后,已决定用缬更昔洛韦治疗患者并停止免疫抑制。他的症状迅速缓解,开始治疗后3个月重复进行血浆PCR检测HHV-8阴性。后续CT扫描显示淋巴结肿大和数量明显减少。经过15个月的治疗,他保持良好状态,没有移植功能障碍或排斥反应的迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号